Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.56 |
| ▸ | DGKA | P23743 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.52 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.48 |
| ▸ | SI | P14410 | 1/20 | 0.48 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.47 |
| ▸ | PGR | P06401 | 1/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31049888 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL52706 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL31049893 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL31049856 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL318062 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL1005765 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL24597734 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL47126 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL1703446 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 | |
| SCHEMBL31049851 | 1.00 | CYP1A2 (0.59) | CYP1A2ALDH1A1TRPA1DGKAALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250361250-A1 | FLUORINE-CONTAINING SILANE COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2025-11-27 | — | — | US | disclosed |
| WO-2024172034-A1 | FLUORINE-CONTAINING SILANE COMPOUND | ダイキン工業株式会社 | 2024-08-22 | — | — | WO | disclosed |
| WO-2022144920-A1 | ATOVAQUONE PRODRUGS | IPCA LABORATORIES LIMITED (IN) | 2022-07-07 | — | — | WO | disclosed |
| WO-2022144920-A1 | ATOVAQUONE PRODRUGS | IPCA LABORATORIES LIMITED (IN) | 2022-07-07 | — | — | WO | disclosed |
| US-20210300876-A1 | DIENE GEMINI POLYMERIZABLE SURFACTANTS WITH MIXED CIS AND TRANS ISOMERS THAT FORM BICONTINUOUS CUBIC PHASES | TDA RESEARCH, INC. | 2021-09-30 | — | — | US | disclosed |
| US-7504477-B2 | Polyalkylene glycol acid additives | HOFFMANN-LA ROCHE INC. (US) | 2009-03-17 | — | — | US | disclosed |
| CN-100337689-C | Polyalkylene glycol acid adducts | HOFFMANN LA ROCHE (CH) | 2007-09-19 | — | — | CN | disclosed |
| US-7193031-B2 | Polyalkylene glycol acid additives | HOFFMANN-LA ROCHE INC. (US) | 2007-03-20 | — | — | US | disclosed |
| US-20060167218-A1 | Polyalkylene glycol acid additives | HOFFMANN-LA ROCHE INC. | 2006-07-27 | — | — | US | disclosed |
| CN-1671422-A | Polyalkylene glycol acid additives | HOFFMANN LA ROCHE (CH) | 2005-09-21 | — | — | CN | disclosed |
| EP-1526872-A1 | POLYALKYLENE GLYCOL ACID ADDITIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2005-05-04 | — | — | EP | disclosed |
| US-20040106747-A1 | Polyalkylene glycol acid additives | HOFFMANN-LA ROCHE INC. | 2004-06-03 | — | — | US | disclosed |
| WO-2004012773-A1 | POLYALKYLENE GLYCOL ACID ADDITIVES | F. HOFFMANN-LA ROCHE AG (CH) | 2004-02-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250361250-A1 | FLUORINE-CONTAINING SILANE COMPOUND | FLI1, AFF1, RFT1 | CYP1A2 428/4885ALDH1A1 879/4885TRPA1 3963/4885 |
| US-20210300876-A1 | DIENE GEMINI POLYMERIZABLE SURFACTANTS WITH MIXED CIS AND TRANS ISOMERS THAT FORM BICONTINUOUS CUBIC PHASES | GMNN, GEMIN4, PHOSPHO1 | CYP1A2 4457/4885ALDH1A1 4713/4885TRPA1 1993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.